As Streptococcus A cases continue to be prevalent, a new nasal vaccine could provide long-term protection from the deadly bacteria. The development of a Strep A vaccine which is currently in Phase 1 clinical trials in Canada and quickly advancing to Phase 2 efficacy trials.
from Top Health News -- ScienceDaily https://ift.tt/0J8tSoI
Post a Comment